Evidence map›Paper›PMID 19707598›Full record

ArticlePloS one2009

In vivo expression of MHC class I genes depends on the presence of a downstream barrier element.

Helit Cohen, Palak Parekh, Zeynep Sercan, Aparna Kotekar, Jocelyn D Weissman, Dinah S Singer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Helit CohenExperimental Immunology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA.
Palak Parekh
Zeynep Sercan
Aparna Kotekar
Jocelyn D Weissman
Dinah S Singer
National Institutes of Health · USCenter for Cancer Research · US

Funding

Application of Flow Cytometry to Cell BiologyZICBC009255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CROSSMAN, ASSIATU · 2009 to 2025
$26.4M
APPLICATION OF FLOW CYTOMETRY TO CELL BIOLOGYZ01BC009255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHARROW, SUSAN · 1996 to 2008
$3.0M
Intramural NIH HHS
6 · The paper itself

Abstract

Regulation of MHC class I gene expression is critical to achieve proper immune surveillance. In this work, we identify elements downstream of the MHC class I promoter that are necessary for appropriate in vivo regulation: a novel barrier element that protects the MHC class I gene from silencing and elements within the first two introns that contribute to tissue specific transcription. The barrier element is located in intergenic sequences 3' to the polyA addition site. It is necessary for stable expression in vivo, but has no effect in transient transfection assays. Accordingly, in both transgenic mice and stably transfected cell lines, truncation of the barrier resulted in transcriptional gene silencing, increased nucleosomal density and decreased histone H3K9/K14 acetylation and H3K4 di-methylation across the gene. Significantly, distinct sequences within the barrier element govern anti-silencing and chromatin modifications. Thus, this novel barrier element functions to maintain transcriptionally permissive chromatin organization and prevent transcriptional silencing of the MHC class I gene, ensuring it is poised to respond to immune signaling.

Indexed as

Gene ExpressionGenes, MHC Class IAcetylationAnimalsBase SequenceBlotting, NorthernChromatin ImmunoprecipitationCpG IslandsDNA PrimersGene SilencingIntronsMiceMice, TransgenicPromoter Regions, GeneticReverse Transcriptase Polymerase Chain ReactionTranscription, GeneticDNA Primers

Identifiers

PMID19707598
PMCPMC2727697
OpenAlexW2169657386

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.